Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain (DISCERV)
Pain, Cervical, Discogenic Pain
About this trial
This is an interventional treatment trial for Pain, Cervical
Eligibility Criteria
Inclusion Criteria: Patient 18 years or older; Pain refractory to conservative treatments for more than 2 months, non-surgical patients Cervicobrachialgia due to disc herniation Chronic discogenic pain (1 or 2 cervical discs) with concordant MRI; Patient agreeing to participate in the study and having given written consent; Patient enrolled in a health insurance plan. Exclusion Criteria: Prior surgical treatment of the disc(s) studied; Sick leave of more than 12 months secondary to painful symptoms; Patient with Modic 1 score or more History of cognitive-behavioral disorders that could affect the completion of self-questionnaires; Local or systemic infection, or suspicion of infection; Severe coagulation disorders; Other inflammatory rheumatic disease; Severe underlying pathology with life expectancy <1 year; Women of childbearing age who are pregnant at the inclusion visit or who wish to become pregnant before the administration of the treatment (V0); Known allergy to contrast material and/or local anesthetic substances; Patients who cannot read or write Italian; Major person benefiting from a legal protection regime (guardianship, curatorship, safeguard of justice);
Sites / Locations
- Santissima Trinità Hospital Ascagliari
- Azienda Ospedaliera Universitaria
Arms of the Study
Arm 1
Experimental
Intradiscal Gelified Ethanol Arm
Patients who come with symptomatic cervical disc herniation or with cervical discogenic pain and meet the eligibility criteria.